← FDA DRUG APPROVALS

FDA NDA · NDA209511

XARACOLL

Sponsor: INNOCOLL PHARMS

APPLICATION
NDA209511
TYPE
NDA
ORIGINAL APPROVAL
2020-08-28
LATEST ACTION
2020-08-28
ROUTE
IMPLANTATION
DOSAGE FORM
IMPLANT
MARKETING STATUS
Discontinued

Products

XARACOLL · ReferenceDiscontinued
BUPIVACAINE HYDROCHLORIDE 100MG · IMPLANT · IMPLANTATION

Approval history

2020-08-28Type 3 - New Dosage Form and Type 4 - New Combination · Original · standard — Letter ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →